Literature DB >> 1370726

Cytogenetic and survival adaptive responses in G1 phase human lymphocytes.

J D Shadley1, G Q Dai.   

Abstract

Human lymphocytes from six donors were treated with 5 cGy of X-rays followed by 200 or 400 cGy in the first G1 phase after PHA stimulation, and assayed for cytogenetic aberrations and cell survival. Four donors showed cytogenetic adaptive responses with 400 cGy, and one with both 200 cGy and 400 cGy. Both exchanges and deletions were reduced, indicating that the cytogenetic adaptive response acts by restitution of chromosome breaks. Good correlations were found between nonaberrant cells and survival, although the former were often higher than the later, especially with the 400 cGy dose. In four of six donors, 5 cGy alone had significant effects on cell survival; however, this was independent of the 5 cGy effect on high-dose-induced responses. Two donors had survival adaptive responses with 5 + 200 cGy, while none were found with the 5 + 400 cGy treatment. The comparisons between the cytogenetic and survival responses suggests that a survival adaptive response will only be seen with a sufficient increase in nonaberrant cells. To date, adaptive responses to ionizing radiation have been reported to occur in G0, G1 and late S/early G2 human lymphocytes.

Entities:  

Mesh:

Year:  1992        PMID: 1370726     DOI: 10.1016/0027-5107(92)90056-8

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  13 in total

1.  Is it really this simple?

Authors:  Martin Charron; Brian C Lentle
Journal:  Pediatr Radiol       Date:  2003-09-16

2.  Transcription profile of DNA damage response genes at G₀ lymphocytes exposed to gamma radiation.

Authors:  Divyalakshmi Saini; Shridevi Shelke; A Mani Vannan; Sneh Toprani; Vinay Jain; Birajalaxmi Das; M Seshadri
Journal:  Mol Cell Biochem       Date:  2012-01-19       Impact factor: 3.396

3.  SOD2-mediated effects induced by WR1065 and low-dose ionizing radiation on micronucleus formation in RKO human colon carcinoma cells.

Authors:  Jeffrey S Murley; Yasushi Kataoka; Richard C Miller; Jian Jian Li; Gayle Woloschak; David J Grdina
Journal:  Radiat Res       Date:  2010-11-08       Impact factor: 2.841

4.  A rebuttal to chiropractic radiologists' view of the 50-year-old, linear-no-threshold radiation risk model.

Authors:  Paul A Oakley; Donald D Harrison; Deed E Harrison; Jason W Haas
Journal:  J Can Chiropr Assoc       Date:  2006-09

5.  SOD2-mediated adaptive responses induced by low-dose ionizing radiation via TNF signaling and amifostine.

Authors:  J S Murley; K L Baker; R C Miller; T E Darga; R R Weichselbaum; D J Grdina
Journal:  Free Radic Biol Med       Date:  2011-09-03       Impact factor: 7.376

Review 6.  Dose-response relationship for radiation carcinogenesis in the low-dose region.

Authors:  B L Cohen
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

7.  Adaptive response to mutagenesis and its molecular basis in a human T-cell leukemia line primed with a low dose of gamma-rays.

Authors:  P K Zhou; X Q Xiang; W Z Sun; X Y Liu; Y P Zhang; K Wei
Journal:  Radiat Environ Biophys       Date:  1994       Impact factor: 1.925

8.  No indications of an enhanced UV-light-induced unscheduled DNA synthesis in splenocytes of mice following a low-dose irradiation in vivo or in vitro.

Authors:  A Wojcik; C A Seemayer; W U Müller; C Streffer
Journal:  Radiat Environ Biophys       Date:  1995-06       Impact factor: 1.925

9.  DNA-dependent protein kinase does not play a role in adaptive survival responses to ionizing radiation.

Authors:  E Odegaard; C R Yang; D A Boothman
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

10.  Adaptive response in human blood lymphocytes exposed to non-ionizing radiofrequency fields: resistance to ionizing radiation-induced damage.

Authors:  Anna Sannino; Olga Zeni; Stefania Romeo; Rita Massa; Giancarlo Gialanella; Gianfranco Grossi; Lorenzo Manti; Maria Rosaria Scarfì
Journal:  J Radiat Res       Date:  2013-08-26       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.